The invention is directed to compounds that are P2X
7
antagonist and have the formula (I) or (II)
or a pharmaceutically acceptable salt, prodrug, salt of a prodrug or a combination thereof, wherein R
1
, R
2
, and R
3
are defined in the specification. The invention is also directed to a method of selectively inhibiting P2X
7
activity comprising administering to a patient in need of such treatment a therapeutically effective amount of a compound of formula (III), (IV) or (V)
wherein R
6
, R
7
, R
8
, R
9
, R
10
, and R
11
are defined in the specification.
Facile Synthesis of Halogen Decorated para-/meta-Hydroxybenzoates by Iridium-Catalyzed Borylation and Oxidation
作者:Ghayoor Chotana、Tayyaba Shahzadi、Rahman Saleem
DOI:10.1055/s-0037-1610538
日期:2018.11
food and pharmaceutical industries. In this report, a facile preparation of 2,6- and 2,3-disubstituted 4/5-hydroxybenzoates by iridium-catalyzed borylation of respective disubstituted benzoate esters followed by oxidation is described. This synthetic route allows for the incorporation of halogens in the final hydroxybenzoates with substitution patterns not readily accessible by the traditional routes